These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 31453969)
21. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study. Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause. Barba M; Cola A; De Vicari D; Costa C; Castelli AP; Volontè S; Fruscio R; Frigerio M Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892888 [TBL] [Abstract][Full Text] [Related]
23. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800 [TBL] [Abstract][Full Text] [Related]
24. Number of vaginal lactobacilli in postmenopausal women with vaginal atrophy before and after treatment with erbium-YAG laser: a randomized sham-controlled trial. Panyawongudom N; Panyakhamlerd K; Suwan A BMC Womens Health; 2023 Sep; 23(1):513. PubMed ID: 37752478 [TBL] [Abstract][Full Text] [Related]
25. Vaginal CO Pearson A; Booker A; Tio M; Marx G Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895 [TBL] [Abstract][Full Text] [Related]
26. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results. Athanasiou S; Pitsouni E; Grigoriadis T; Zacharakis D; Falagas ME; Salvatore S; Protopapas A; Loutradis D Menopause; 2019 Mar; 26(3):248-255. PubMed ID: 30252804 [TBL] [Abstract][Full Text] [Related]
27. The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress urine incontinence and sexual dysfunction. Lin HY; Tsai HW; Tsui KH; An YF; Lo CC; Lin ZH; Liou WS; Wang PH Taiwan J Obstet Gynecol; 2018 Dec; 57(6):825-829. PubMed ID: 30545535 [TBL] [Abstract][Full Text] [Related]
28. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis. Jha S; Wyld L; Krishnaswamy PH Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the efficacy of fractional CO Sindou-Faurie T; Louis-Vahdat C; Oueld Es Cheikh E; Canlorbe G; Mergui JL; Uzan C; Azaïs H Arch Gynecol Obstet; 2021 Apr; 303(4):955-963. PubMed ID: 33179118 [TBL] [Abstract][Full Text] [Related]
30. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial. Hersant B; Werkoff G; Sawan D; Sidahmed-Mezi M; Bosc R; La Padula S; Kalsoum S; Ouidir N; Meningaud JP; Belkacemi Y Ann Chir Plast Esthet; 2020 Jul; 65(4):e23-e31. PubMed ID: 32513482 [TBL] [Abstract][Full Text] [Related]
32. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Sokol ER; Karram MM Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913 [TBL] [Abstract][Full Text] [Related]
33. Genitourinary syndrome of menopause (GSM) and laser VEL: a review. Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction. Vale F; Rezende C; Raciclan A; Bretas T; Geber S Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618 [TBL] [Abstract][Full Text] [Related]
35. A study of the objective benefits and safety of Er-YAG laser in the treatment of genitourinary syndrome of menopause. Avul Z; Guven CM Lasers Med Sci; 2023 Jun; 38(1):131. PubMed ID: 37270721 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; BSc AB; Martel C; Vaillancourt M; Balser J; Moyneur É; Menopause; 2018 Nov; 25(11):1339-1353. PubMed ID: 30358731 [TBL] [Abstract][Full Text] [Related]
37. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Vicariotto F; Raichi M Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062 [TBL] [Abstract][Full Text] [Related]
38. Vulvar and vaginal fractional CO2 laser treatments for genitourinary syndrome of menopause. Streicher LF Menopause; 2018 May; 25(5):571-573. PubMed ID: 29406425 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials. Pitsouni E; Grigoriadis T; Douskos A; Kyriakidou M; Falagas ME; Athanasiou S Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():45-56. PubMed ID: 30103082 [TBL] [Abstract][Full Text] [Related]